Skip to main content
Top

A Narrative Review on Sleep and Eating Behavior

Published in:

Abstract

Purpose of Review

This narrative review synthesizes current evidence on the role of various sleep parameters—including sleep duration, sleep quality, sleep timing, social jetlag, and chronotype—in energy intake, macronutrient consumption, diet quality, and meal timing. We aim to evaluate whether existing evidence supports a causal impact of sleep on eating behavior and discuss the clinical implications of these findings for diabetes care and management.

Recent Findings

The impact of short sleep duration on eating behavior is the most widely studied and supported by experimental evidence suggesting that reduced sleep duration increases energy intake and promotes poorer diet quality. Later sleep timing is also associated with increased energy intake and poorer diet quality, and may interact with short sleep duration in influencing eating behavior. Chronotype, social jetlag, and sleep quality have also been linked to eating behavior; however, findings in these areas have been predominantly observational and cross-sectional, and may be confounded by co-occurring influences from other sleep parameters.

Summary

Given the strength of the evidence for the role of sleep duration in eating behavior, future studies should evaluate the feasibility and efficacy of sleep extension interventions for controlling energy intake and improving diet quality in patients with type 2 diabetes. Further research should also clarify and distinguish the independent and interacting influences of multiple sleep parameters on eating behavior, as well as the potential effects of eating behavior on sleep.
Title
A Narrative Review on Sleep and Eating Behavior
Authors
Wing Yee Cheng
Wai Sze Chan
Publication date
30-09-2025
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 1/2025
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-025-01611-4
This content is only visible if you are logged in and have the appropriate permissions.

Raising the standard: ensuring patient safety through minimum requirements for CGM performance

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by:
  • Abbott Diabetes Care
Prof. Chantal Mathieu
Developed by: Springer Health+
Watch now
Video

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits
Hands reaching for donut/© Andriy / Stock.adobe.com, Woman monitoring glucose level with sensor and an app on her phone while training at swimming pool/© (M) Goffkein, stock.adobe.com (symbolic image with model), Person walking/© _KUBE_ / Stock.adobe.com